Atorvastatin,Placebo

3 trials

Sponsors

Faculty of Medicine Chiang Mai University, Ratchadapisek Somphot Fund, Faculty of Medicine Research Grant Khon Kaen University

Conditions

Aggressive non&#45Decompensated Liver cirrhosis Atorvastatin, liver cirrhosis, transient elastographyPatients with chronic kidney disease stage 3&#45

Phase 2

Efficacy of Atorvastatin on Prevent of First Decompensation in Patients with High-Risk Compensated Liver Cirrhosis : A Prospective Randomized Double-blind Placebo-Controlled Trial

RecruitingTCTR20250624005

Faculty of Medicine Research Grant Khon Kaen UniversityDecompensated Liver cirrhosis Atorvastatin, liver cirrhosis, transient elastography

Start: 2025-06-17Target: 159Updated: 2026-08-03

Phase 3

Cardioprotective Effect of Atorvastatin in Lymphoma Patients Receiving CHOP/R-CHOP regimen, A Randomized Control Trial

RecruitingTCTR20180202004

Faculty of Medicine Chiang Mai UniversityAggressive non&#45

Start: 2018-01-23Target: 72Updated: 2026-08-03

Atorvastatin for Renoprotective Effects in contrast-induced NephropAthy prevention

Active, not recruitingTCTR20180816001

Ratchadapisek Somphot FundPatients with chronic kidney disease stage 3&#45

Start: 2018-12-01Target: 257Updated: 2026-08-03